Illingworth's CRO Team
An Introduction to Key Members of Our Team
Illingworth Research Group appreciates a vital component in delivering projects successfully is developing a strong relationship between the sponsor and CRO. This is why we place great emphasis on attracting, training and retaining excellent industry talents, to deliver excellent service to our sponsors. As a family owned and run business, the company offers open communication with a flexible and supportive approach, meaning our CRO services are unique in that we can offer a more personal touch.
John Illingworth, Chief Executive Officer
Having gained over 30 years of experience, initially at ICI (now AstraZeneca) and then at Serono, John became a freelance Clinical Research Manager in 1996. He founded Clinical Development and Support Services Ltd (CDSS) in 1998. John spent 10 years teaching on the MSc in Clinical Research, Diploma and Certificate courses at Liverpool John Moores University and is still an honorary lecturer there. He was on the executive committee of the Association of Clinical Research in the pharmaceutical industry (now the Institute for Clinical Research) for 6 years.
Whilst gaining his Institute of Directors Diploma in company direction, John continued to oversee the steady expansion of CDSS, promoting the company both within the UK and overseas to the biotech, pharmaceutical and medical device industries and is a familiar and respected face at conferences, exhibitions and seminars all over the world.
Following the expansion of CDSS and the growth of its contract research nursing operation to become the leading independent supplier of research nurses in the UK, John oversaw the strategic realignment of the company in 2011 to become Illingworth Research Ltd and ResearchNurses.co allowing both companies to focus on their core business of clinical trial management and contract supply of Research Nurses respectively.
Dr Mike Davies, Chief Medical Officer
A high achieving Medic and Surgeon and latterly senior pharmaceutical executive whose broad experience and understanding of the clinical research environment provides an invaluable resource for the Illingworth Research team.
His significant history in both medicine and surgery facilitated his transition into pharmaceutical medicine, where he developed over ten patents for work in the discovery of wound healing, dermatology and cardiovascular compounds. Mike has provided scientific and medical expertise and leadership to a global product strategy from concept through to registration and throughout the life-cycle of important and valuable medical compounds.
Having completed clinical research in all four phases of drug development and gained extensive experience in areas of drug development and marketing, Mike now provides consultancy advice on pharmaceutical and clinical affairs.
View profile and connect on LinkedIn
Yvonne joined Illingworth Research Group over 4 years’ ago. She has over 14 years’ experience in clinical research; 4 years as PM/Sen CRA, 8 years monitoring in both non-commercial and commercial settings, in Phases I to III, in therapeutic areas including chronic refractory cough, asthma, RSV, Cardiogenic Pulmonary Oedema and cardiac markers. Prior to this, she worked in general nursing.
Yvonne has experience within the pharmaceutical industry working within a Phase I unit running PK studies in both healthy volunteer and patient studies, covering a wide range of therapeutic areas. Yvonne uses her background in nursing to compliment her Project Management and Monitoring skills which allows for significant appreciation of the challenges faced when dealing with study sites. Additionally, Yvonne has extensive experience working in Emergency Medicine research, including medical device studies. She has many years working as a general nurse in Liver transplantation, general medicine, renal and respiratory care.